ALEXIS AHLBERG: Open Payments
NPI 1396330288 · CEDAR RAPIDS, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,333 in 65 payments from 18 companies in 2025. Trend: 2023 $642 · 2024 $870 · 2025 $1,333
Food & beverage: $1,333
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $323 |
| Janssen Biotech, Inc. | 10 | $274 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $188 |
| Celltrion USA Inc. | 5 | $90 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $62 |
| Lilly USA, LLC | 3 | $55 |
| Madrigal Pharmaceuticals | 3 | $52 |
| Phathom Pharmaceuticals, Inc. | 3 | $44 |
| Ardelyx, Inc. | 2 | $38 |
| Regeneron Healthcare Solutions, Inc. | 2 | $37 |
Products named: TREMFYA, SKYRIZI, EOHILIA, ENTYVIO, VEGZELMA, RINVOQ, XIFAXAN, OMVOH.
Industry payments across IA — which companies pay providers there.
